Endo Health buys migraine patch-maker for $105M

12/17/2013 | Reuters

Endo Health Solutions agreed to pay about $105 million to acquire NuPathe and its lead product Zecuity, the only FDA-approved prescription patch for migraine. The acquisition could be finalized early next year, and Endo plans to commercialize the migraine patch in the first half of 2014.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
CareFusion
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations